Notice of Intent to Sole Source: Vaccine Adverse Event Reporting System (VAERS) & Safety Monitoring Support
Special Notice monitored from sam-gov.
- Buyer / agency
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF
- Notice type
- Special Notice
- Solicitation number
- CBER-2026-133723
- Posted
- September 10, 2026
- Response deadline
- September 18, 2026
- Location
- CA, US
- Estimated value
- Not published by the source
- NAICS
- 541720
- Source
- sam-gov
Summary
The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER)�s Office of Biostatistics and Pharmacovigilance (OPBV)�s Division of Pharmacovigilance (DPV) is responsible for monitoring the safety of vaccines and biologics once they are approved for use under a Biologic Licensing Application (BLA) or authorized for use under an Emergency Use Authorization (EUA). The Contractor shall furnish the necessary services and qualified personnel needed to p…
See the official source link, all documents, and the full solicitation text — and prepare a proposal working draft with AI — with a free Octobid account.
Summaries are indexed from official public sources; the issuing platform’s notice, documents, and amendments always control.